Home Applications 020671 Application 020671
Type NDA
Sponsor NOVARTIS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 HYCAMTIN TOPOTECAN HYDROCHLORIDE INJECTABLE;INJECTION EQ 4MG BASE/VIAL Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N020671-001 HYCAMTIN TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-28
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N020671-001 AP
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-01 22:54:32 2026-06 N020671-001 HYCAMTIN EQ 4MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-28 a50c72e98297…
Observed Orange Book normalized TE history# Captured, Edition, Application-product table Captured Edition Application-product TE code Order Source SHA-256 2026-08-01 22:54:32 2026-06 N020671-001 AP 1 a50c72e98297…
openFDA label cross-check# Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join HYCAMTIN TOPOTECAN HYDROCHLORIDE Novartis Pharmaceuticals Corporation eeee060c-a9ec-423e-a374-8484009f8524 2022-07-07 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 020671 application number: NDA020671 ndc (product): 0078-0674
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 6 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0078-0674 HYCAMTIN topotecan hydrochloride Novartis Pharmaceuticals Corporation NDA Current 0078-0674 HYCAMTIN topotecan hydrochloride Novartis Pharmaceuticals Corporation NDA Current 0078-0674 HYCAMTIN topotecan hydrochloride Novartis Pharmaceuticals Corporation NDA Current 0078-0674 HYCAMTIN topotecan hydrochloride Novartis Pharmaceuticals Corporation NDA Current 0078-0674 HYCAMTIN topotecan hydrochloride Novartis Pharmaceuticals Corporation NDA Current 0078-0674 HYCAMTIN topotecan hydrochloride Novartis Pharmaceuticals Corporation NDA Current